The trademark application FOPSIVVA was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 30, 2020, and it was registered by office on December 7, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).